[1] PARKER J, MURPHY M, HUEFFER K, et al.Investigation of a Canine parvovirus outbreak using next generation sequencing[J].Scientific Reports, 2017, 7(1):9633. [2] LIU F X, LIN J H, WANG Q Q, et al.In vitro recovery of recombinant Canine distemper virus that expresses CPV-2a VP2:Uncovering the mutation profile of recombinant undergoing 50 serial passages[J].Frontiers in Cellular and Infection Microbiology, 2021, 11:770576. [3] TUTEJA D, BANU K, MONDAL B, et al.Canine parvovirology:A brief updated review on structural biology, occurrence, pathogenesis, clinical diagnosis, treatment and prevention[J].Comparative Immunology, Microbiology and Infectious Diseases, 2022, 82:101765. [4] LI G, JI S L, ZHAI X, et al.Evolutionary and genetic analysis of the VP2 gene of Canine parvovirus[J].BMC Genomics, 2017, 18:534. [5] ZHOU P, ZENG W J, ZHANG X, et al.The genetic evolution of Canine parvovirus:A new perspective[J].PLoS One, 2017, 12(3):e0175035. [6] BATTILANI M, SCAGLIARINI A, TISATO E, et al.Analysis of Canine parvovirus sequences from wolves and dogs isolated in Italy[J]. Journal of General Virology, 2001, 82:1555-1560. [7] MIRANDA C, THOMPSON G.Canine parvovirus, the worldwide occurrence of antigenic variants[J].Journal of General Virology, 2016, 97(9):2043-2057. [8] 徐进, 孙世琪, 曹随忠, 等.犬细小病毒病基因工程疫苗的研究进展[J].中国兽医科学, 2012, 42(5):541-544. XU J, SUN S Q, CAO S Z, et al.Progress in genetic engineering vaccines against Canine parvovirus[J].Chinese Veterinary Science, 2012, 42(5):541-544.(in Chinese) [9] IIDA H, FUKUDA S, KAWASHIMA N, et al.Effect of maternally derived antibody levels on antibody responses to Canine parvovirus, Canine distemper virus and infectious Canine hepatitis virus after vaccinations in Beagle puppies[J].Jikken Dobutsu Experimental Animals, 2010, 39(1):9. [10] WILSON S, ILLAMBAS J, SIEDEK E, et al.Vaccination of dogs with Canine parvovirus type 2b (CPV-2b)induces neutralizing antibody responses to CPV-2a and CPV-2c[J].Vaccine, 2014, 32(42):5420-5424. [11] NELSON C D S, PALERMO L M, HAFENSTEIN S L, et al.Different mechanisms of antibody-mediated neutralization of Parvoviruses revealed using the Fab fragments of monoclonal antibodies[J].Virology, 2007, 361(2):283-293. [12] HAMERS-CASTERMAN C, ATARHOUCH T, MUYLDERMANS S, et al.Naturally occurring antibodies devoid of light chains[J].Nature, 1993, 363(6428):446-448. [13] DMITRIEV O Y, LUTSENKO S, MUYLDERMANS S, et al.Nanobodies as probes for protein dynamics in vitro and in cells[J]. Journal of Biological Chemistry, 2016, 291(8):3767-3775. [14] 王天宇, 李志伟, 杨婷, 等.猪流行性腹泻病毒S蛋白纳米抗体的筛选与鉴定[J].畜牧兽医学报, 2021, 52(9):2589-2598. WANG T Y, LI Z W, YANG T, et al.Screening and identification of nanobodies against Porcine epidemic diarrhea virus S protein[J].Acta Veterinaria et Zootechnica Sinica, 2021, 52(9):2589-2598.(in Chinese) [15] YAKUSHI T, MASUDA K, NARITA S, et al.A new ABC transporter mediating the detachment of lipid-modified proteins from membranes[J].Nature Cell Biology, 2000, 2:212-218. [16] LENKA P, MANGESH B, LUCIA B P, et al.An introduction to B-cell epitope mapping and in silico epitope prediction[J].Journal of Immunology Research, 2016, 2016:6760830. [17] BAI Y, CHEN Y M, ZHANG N, et al.Isolation of the neutralization scFvs against HBV infection from the immunized population[J].Current Pharmaceutical Biotechnology, 2015, 16(10):902-910. [18] EUGSTER A K, NAIRN C.Diarrhea in puppies:Parvovirus-like particles demonstrated in their feces[J].Southwestern Veterinarian, 1977, 30(1):59-60. [19] ZHOU H, ZHANG Y L, LU G, et al.Recombinant antibody libraries and selection technologies[J].New Biotechnology, 2011, 28(5):448-452. [20] MIROUX B, WALKER J E.Over-production of proteins in Escherichia coli:Mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels[J].Journal of Molecular Biology, 1996, 260(3):289-298. [21] 傅俊华, 王琪, 尹杰超, 等.融合蛋白GST-Ulp1p在大肠杆菌中的高效可溶性表达及其活性鉴定[J].生物工程学报, 2010, 26(6):837-842. FU J H, WANG Q, YIN J C, et al.Expression and characterization of soluble recombinant Ulp1p with glutathione S-transferase tag in Escherichia coli[J].Chinese Journal of Biotechnology, 2010, 26(6):837-842.(in Chinese) [22] 李宁, 徐黎明, 李天鹤, 等.具有中和活性的抗人IL-1β单链抗体的构建[J].免疫学杂志, 2011, 28(7):594-598. LI N, XU L M, LI T H, et al.Construction of anti-hIL-1β scFv with neutralizing activity[J].Immunological Journal, 2011, 28(7):594-598.(in Chinese) [23] 李天鹤, 任桂萍, 徐黎明, 等.抗人IL-1β单链抗体的构建及其中和活性的检测[J].中国免疫学杂志, 2013, 29(3):304-310. LI T H, REN G P, XU L M, et al.Construction of anti-hIL-1β scFv with neutralizing activity[J].Chinese Journal of Immunology, 2013, 29(3):304-310.(in Chinese) [24] MORENO E, VALDéS-TRESANCO MARIO S, MOLINA-ZAPATA A, et al.Structure-based design and construction of a synthetic phage display nanobody library[J].BMC Research Notes, 2022, 15:124. [25] STIJLEMANS B, CONRATH K, CORTEZ-RETAMOZO V, et al.Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies.African trypanosomes as a paradigm[J].Journal of Biological Chemistry, 2004, 279(2):1256-1261. [26] PI X L, WANG Y Y, ZOU Y M, et al.Generation of a Canine-origin neutralizing scFv against Canine parvovirus[J].Journal of Northeast Agricultural University (English Edition), 2020, 27(3):45-52. [27] 刘欢.抗犬细小病毒单链抗体的制备[D].秦皇岛:河北科技师范学院, 2016. LIU H.Preparation of single-chain antibody against Canine parvovirus[D].Qinhuangdao:Hebei Normal University of Science and Technology, 2016.(in Chinese) [28] LANGEVELD J P, CASAL J I, OSTERHAUS A D, et al.First peptide vaccine providing protection against viral infection in the target animal:Studies of Canine parvovirus in dogs[J].Journal of Virology, 1994, 68(7):4506-4513. |